https://www.selleckchem.com/pr....oducts/bleximenib-ox
garding esophageal dilation progression different in early versus longstanding SSc-ILD is needed. Key Points •In early SSc-ILD patients, we demonstrated that a worsening esophageal diameter was a predictor of progression of HRCT score at 1-year follow-up. •Further study regarding the association of worsening of the esophageal dilatation with the progression of ILD comparing between early versus late SSc-ILD is needed. Prior opioid use can influence outcomes for patients with musculoskeletal disorders. The purpose of this stud
Beğen
Yorum Yap
Paylaş
